Correlation between variation in quality of life and change in hemoglobin level after treatment with epoetin alfa 40,000 IU administered once-weekly

Supportive Care in Cancer

Volumn 15, Issue 9, 2007, Pages 1057-1066

  Cartenì, Giacomo ^a   Giannetta, Laura ^b   Ucci, Giovanni ^c   De Signoribus, Giorgio ^d   Vecchione, Aldo ^e   Pinotti, Graziella ^f   Puglisi, Fabio ^g   Contillo, Antonio ^h   Pezzella, Giuseppe ⁱ   Orecchia, Simona ^j   Beccaglia, Patrizia ^j   Adamo, V ^k   Aglietta, M ^k   Alabiso, O ^k   Altavilla, G ^k   Amadori, D ^k   Amunni, G ^k   Bajetta, E ^k   Bobbio Pallavicini, E ^k   Bonsignori, M ^k   Bordonaro, R ^k   Bottini, A ^k   Catalano, G ^k   Chiavacci, A ^k   Cigolari, S ^k   Ciotti, R ^k   Conte, P ^k   Ricci, S ^k   Contillo, A ^k   Contu, A ^k   Cortesi, E ^k   Crispino, S ^k   D'Aprile, M ^k   De Chiara, A ^k   De Signoribus, G ^k   Del Prete, S ^k   Donghi, M ^k   Antonelli, P ^k   Falcone, A ^k   Fioretto, L ^k   Fornasiero, A ^k   Gamucci, T ^k   Ghezzi, P ^k   Giusto, M ^k   Iacono, C ^k   Lombardo, M ^k   Manente, P ^k   Mantovani, G ^k   Marchetti, P ^k   Masina, A ^k   Mattioli, R ^k   Menichetti, E ^k   Minisini, A ^k   Neri, B ^k   Nettuno, R ^k   Palazzo, S ^k   Palmeri, S ^k   Palmiotti, G ^k   Patrone, F ^k   Pezzella, G ^k   Pinotti, G ^k   Pizza, C ^k   Pollera, F ^k   Savarese, A ^k   Savarino, A ^k   Sbalzarini, G ^k   Serravezza, G ^k   Siena, S ^k   Sobrero, A ^k   Surace, G ^k   Vecchione, A ^k   Vietti Ramus G , ^k   Vinante, O ^k   Zagonel, V ^k   more..

^a CARDARELLI HOSPITAL   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

^c Medical Oncology A Manzoni H   (Italy)

^d Casa Sollievo Sofferenza   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f Medical Oncology   (Italy)

^g UNIVERSITY OF UDINE   (Italy)

^h OSPEDALI RIUNITI   (Italy)

ⁱ Medical Oncology SS: Annunziata H   (Italy)

^j Janssen Cilag SpA Italia   (Italy)

^k NONE

more..

Author keywords

Anemia; Epoetin alfa; Once weekly; Quality of life; Solid tumors

Indexed keywords

HEMOGLOBIN; IRON; RECOMBINANT ERYTHROPOIETIN;

ABDOMINAL PAIN; ADULT; ANEMIA; ARTICLE; ASTHENIA; BLOOD TRANSFUSION; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL TRIAL; CORRELATION ANALYSIS; DISEASE COURSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FEVER; FUNCTIONAL ASSESSMENT; GRANULOCYTOPENIA; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; LEUKOPENIA; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; QUALITY OF LIFE; THROMBOCYTOPENIA; THROMBOEMBOLISM; VOMITING;

AGED; ANEMIA; ANTINEOPLASTIC AGENTS; EPOETIN ALFA; FEMALE; HEMATINICS; HEMOGLOBINS; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; QUALITY OF LIFE;

EID: 34548307145     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-007-0220-4     Document Type: Article

References (29)

1. Ludwig H, Van Belle S, Barrett-Lee P et al (2004) The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer 40:2293-2306
2. Cella D (1997) The Functional Assessment of Cancer Therapy-Anemia (FACT-An) scale: a new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol 34(3 Suppl 2):13-19
3. Cella D (1998) Factors influencing quality of life in cancer patients: anemia and fatigue. Semin Oncol 25(3 Suppl 7):43-46
4. Ludwig H, Fritz E (1998) Anemia in cancer patients. Semin Oncol 25:2-6
5. Carelle N, Piotto E, Bellanger A et al (2002) Changing patient perceptions of the side effects of cancer chemotherapy. Cancer 95:155-163
6. Lindley C, Vasa S, Sawyer WT et al (1998) Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer. J Clin Oncol 16:1380-1387
7. Bottini A, Berruti A, Brizzi MP et al (2003) Pretreatment haemoglobin levels significantly predict the tumour response to primary chemotherapy in human breast cancer. Br J Cancer 89:977-982
8. Grogan M, Thomas GM, Melamed I et al (1999) The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer 86:1528-1536
9. Caro JJ, Salas M, Ward A et al (2001) Anemia as an independent prognostic factor for survival in patients with cancer: a systematic, quantitative review. Cancer 91:2214-2221
10. Waters JS, O'Brien MER, Littlewood TJ et al (2002) Management of anemia in patients receiving chemotherapy. J Clin Oncol 20:601-603
11. Denis F, Garaud P, Bardet E et al (2004) Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol 22:69-76
12. Abels RI (1992) Use of recombinant human erythropoietin in the treatment of anemia in patients who have cancer. Semin Oncol 19:29-35
13. Littlewood TJ, Bajetta E, Nortier JW et al (2001) Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol 19:2865-2874
14. Glaspy J, Bukowski R, Steinberg D et al (1997) Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group. J Clin Oncol 15:1218-1234
15. Demetri GD, Kris M, Wade J et al (1998) Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group. J Clin Oncol 16:3412-3425
16. Gabrilove JL, Cleeland CS, Livingston RB et al (2001) Clinical evaluation of once-weekly dosing of epoietin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing. J Clin Oncol 19:2875-2882
17. Witzig TE, Silberstein PT, Loprinzi CL et al (2005) Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy. J Clin Oncol 23:2606-2617
18. Cella D (1997) FACIT manual: manual of the Functional Assessment of Chronic Illness Therapy (FACIT) scales. Version 4, Center on Outcomes, Research and Education (CORE), Evanston Northwestern Healthcare and Northwestern University, Evanston, Illinois
19. Shasha D, George MJ, Harrison LB (2003) Once-weekly dosing of epoetin-alpha increases hemoglobin and improves quality of life in anemic cancer patients receiving radiation therapy either concomitantly or sequentially with chemotherapy. Cancer 98:1072-1079
20. Straus DJ, Testa M, Sarokhan B et al (2006) Quality-of-life and health benefits of early treatment of mild anemia: a randomized trial of epoetin alfa in patients receiving chemotherapy for hematologic malignancies. Cancer 107(8):1909-1917
21. Crawford J, Cella D, Cleeland CS et al (2002) Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy. Cancer 95:888-895
22. Lind M, Vernon C, Cruickshank D et al (2002) The level of haemoglobin in anaemic cancer patients correlates positively with quality of life. Br J Cancer 86:1243-1249
23. Fallowfield L, Gagnon D, Zagari M et al (2002) Multivariate regression analyses of data from a randomised, double-blind, placebo-controlled study confirm quality of life benefit of epoetin alfa in patients receiving non-platinum chemotherapy. Br J Cancer 87:1341-1353
24. Cella D, Zagari MJ, Vandoros C et al (2003) Epoetin alfa treatment results in clinically significant improvements in quality of life in anemic cancer patients when referenced to the general population. J Clin Oncol 21:366-373
25. Granetto C, Ricci S, Martoni A et al (2003) Comparing the efficacy and safety of fixed versus weight-based dosing of epoetin alfa in anemic cancer patients receiving platinum-based chemotherapy. Oncol Rep 10:1289-1296
26. Jones M, Schenkel B, Just J et al (2004) Epoetin alfa improves quality of life in patients with cancer: results of a metaanalysis. Cancer 101:1720-1732
27. Fairclough DL, Gagnon DD, Zagari MJ, Marschner, Dicato M, Epoetin Alfa Study Group (2003) Evaluation of quality of life in a clinical trial with nonrandom dropout: the effect of epoetin alfa in anemic cancer patients. Qual Life Res 12:1013-1027
28. Bohlius J, Langensiepen S, Schwarzer G et al (2005) Recombinant human erythropoietin and overall survival in cancer patients: results of a comprehensive meta-analysis. J Natl Cancer Inst 97:489-498
29. Bohlius J, Wilson J, Seidenfeld J et al (2006) Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients. J Natl Cancer Inst 98(10):708-714